N@N

Louise Chen Downgraded (ACRS) to Hold on, Nov 14th, 2023

^{Published on 2024-10-28 07:34:49 - WOPRAI, Louise Chen}
 

Louise Chen of Cantor Fitzgerald, Downgraded "Aclaris Therapeutics, Inc." (ACRS) to Hold on, Nov 14th, 2023.

Louise has made no other calls on ACRS in the last 4 months.

There are 3 other peers that have a rating on ACRS. Out of the 3 peers that are also analyzing ACRS, 2 agree with Louise's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Alex Thompson of "Stifel" Downgraded from Strong Buy to Hold and Decreased Target to $2 on, Monday, November 13th, 2023
• Tim Lugo of "William Blair" Downgraded from Buy to Hold on, Monday, November 13th, 2023

This is the rating of the analyst that currently disagrees with Louise

---

• Gavin Clark-Gartner of "Evercore ISI Group" Initiated at Buy and Held Target at $22 on, Tuesday, October 3rd, 2023

Contributing Sources

---